Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Interest continues in its neuromodulatory and circadian-regulating properties in preclinical and clinical research contexts
Batch-specific documentation, including a Certificate of Analysis, may be available depending on the production lot
Lu S, Yin H, Yu OHY, Azoulay L
made a significant entry into the Indian pharmaceutical market by launching Lirafit, a biosimilar of the widely used anti-diabetic drug liraglutide
US$ 26.01
US$ 21.35
US$ 23.18
US$ 21.74
US$ 24.30
US$ 29.95
US$ 27.98
US$ 21.62
US$ 27.91
US$ 20.04
US$ 27.38
US$ 23.41
US$ 27.05
US$ 29.39
US$ 28.98
US$ 24.69
